Pharmaceutical quality control relies on accurate and efficient identification testing. However, many traditional approaches require extensive manual interpretation, specialist expertise, and physical reference standards.
Download the App note here
As laboratories look to improve productivity while maintaining compliance and data integrity, interest is growing in analytical technologies that can deliver reliable results with greater automation, consistency, and efficiency.
The attached application note explores how automated nuclear magnetic resonance (NMR) workflows are enhancing pharmaceutical identification testing.
It demonstrates how advanced software can automate the entire process from data acquisition and analysis to reporting, thus eliminating routine manual data interpretation while preserving the specificity and robustness that make NMR a valuable tool for quality control.
Using examples from pharmacopoeial methods, the study demonstrates how automated NMR workflows can streamline testing procedures and improve operational efficiency.
Readers will learn how automated identification testing can support routine quality control of pharmaceutical ingredients, reduce reliance on expert analysts, and deliver reliable results across a broad range of testing conditions.
The document also explores the wider potential of automated NMR for both qualitative and quantitative analysis, including the detection and quantification of contaminants in complex samples. As a result, it provides valuable insights for laboratories seeking to modernize their analytical workflows and enhance overall testing performance.
About Bruker BioSpin Group
The Bruker BioSpin Group designs, manufactures, and distributes advanced scientific instruments based on magnetic resonance and preclinical imaging technologies. These include our industry-leading NMR and EPR spectrometers, as well as imaging systems utilizing MRI, PET, SPECT, CT, Optical and MPI modalities. The Group also offers integrated software solutions and automation tools to support digital transformation across research and quality control environments.
Bruker BioSpin’s customers in academic, government, industrial, and pharmaceutical sectors rely on these technologies to gain detailed insights into molecular structure, dynamics, and interactions. Our solutions play a key role in structural biology, drug discovery, disease research, metabolomics, and advanced materials analysis. Recent investments in lab automation, optical imaging, and contract research services further strengthen our ability to support evolving customer needs and enable scientific innovation.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.